Jiangsu Wuzhong Pharmaceutical Development Co.Ltd(600200) donated more than ten million yuan of antiviral drugs

During the critical period of epidemic prevention and control, Jiangsu Wuzhong Pharmaceutical Development Co.Ltd(600200) recently contacted local governments and the Red Cross Society and decided to donate 400000 boxes of abidol hydrochloride tablets (manosu) to fully ensure the demand for first-line anti epidemic drugs.

It is understood that the drug is a broad-spectrum antiviral drug, mainly for the treatment of A, B influenza virus and other respiratory tract infections. Abidol hydrochloride tablets (manosu) produced by Jiangsu Wuzhong Pharmaceutical Development Co.Ltd(600200) has a relatively high market share in the same variety, has the advantage of "integration of raw materials and preparations", and its role and curative effect during the anti epidemic period are affirmed.

As early as in 2020, Wuhan announced the treatment of pneumonia caused by New Coronavirus infection research results showed that in vitro tests showed that New Coronavirus can effectively inhibit New Coronavirus. In 2021, in the article "expert consensus on emergency diagnosis and treatment of adult acute respiratory virus infection" published in the Chinese Journal of emergency medicine, the preventive oral antiviral drug abidol was recommended for the prevention of respiratory virus infection for high-risk groups and exposed susceptible groups. At present, Abi Doll has been included in the diagnosis and treatment plan of New Coronavirus pneumonia (Trial sixth, Seventh Edition, Eighth Edition), and many provinces have included Abi Doll in the list of drug use for anti New Coronavirus pneumonia.

Sun Tianjiang, chairman and general manager of Wuzhong Pharmaceutical Group, said that the 400000 boxes of abidol hydrochloride tablets donated this time were worth more than 10 million yuan. At present, it has connected with the Red Cross Societies in Wuzhong District of Suzhou and Jinhua City of Zhejiang, and completed the first batch of donations of more than 4 million yuan. The company will coordinate logistics and drug distribution channels as planned, and send drugs to communities, isolation points and shelter hospitals as soon as possible, mainly to ensure the health of front-line medical staff and patients.

- Advertisment -